{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:28:05Z","timestamp":1793035685864,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07483-5","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T09:12:10Z","timestamp":1711962730000},"page":"135-144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cost-effectiveness analysis of metformin versus insulin in the treatment of gestational diabetes mellitus"],"prefix":"10.1007","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5352-4506","authenticated-orcid":false,"given":"Rui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0814-8459","authenticated-orcid":false,"given":"Zuojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"issue":"3","key":"7483_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ecl.2019.05.001","volume":"48","author":"ED Szmuilowicz","year":"2019","unstructured":"Szmuilowicz ED, Josefson JL, Metzger BE (2019) Gestational diabetes mellitus. Endocrinol Metab Clin North Am 48(3):479\u2013493. https:\/\/doi.org\/10.1016\/j.ecl.2019.05.001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"7483_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jama.2018.11628","volume":"320","author":"WL Lowe Jr","year":"2018","unstructured":"Lowe WL Jr, Scholtens DM, Lowe LP, Kuang A, Nodzenski M, Talbot O et al (2018) Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA 320(10):1005\u20131016. https:\/\/doi.org\/10.1001\/jama.2018.11628","journal-title":"JAMA"},{"issue":"2 Pt 1","key":"7483_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/AOG.0b013e3181ae8d85","volume":"114","author":"YW Cheng","year":"2009","unstructured":"Cheng YW, Block-Kurbisch I, Caughey AB (2009) Carpenter-Coustan criteria compared with the national diabetes data group thresholds for gestational diabetes mellitus. Obstet Gynecol 114(2 Pt 1):326\u2013332. https:\/\/doi.org\/10.1097\/AOG.0b013e3181ae8d85","journal-title":"Obstet Gynecol"},{"key":"7483_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17249517","author":"J Juan","year":"2020","unstructured":"Juan J, Yang H (2020) Prevalence, prevention, and lifestyle intervention of gestational diabetes mellitus in China. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph17249517","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"7483_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.15537\/smj.2015.4.10307","volume":"36","author":"EM Alfadhli","year":"2015","unstructured":"Alfadhli EM (2015) Gestational diabetes mellitus. Saudi Med J 36(4):399\u2013406. https:\/\/doi.org\/10.15537\/smj.2015.4.10307","journal-title":"Saudi Med J"},{"issue":"1","key":"7483_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13098-022-00900-2","volume":"14","author":"GE Batiha","year":"2022","unstructured":"Batiha GE, Al-Kuraishy HM, Al-Maiahy TJ, Al-Buhadily AK, Saad HM, Al-Gareeb AI et al (2022) Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship. Diabetol Metab Syndr 14(1):127. https:\/\/doi.org\/10.1186\/s13098-022-00900-2","journal-title":"Diabetol Metab Syndr"},{"key":"7483_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012037.pub2","author":"J Brown","year":"2017","unstructured":"Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA (2017) Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD012037.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"7483_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/aog.0000000000002498","volume":"131","author":"AB Caughey","year":"2018","unstructured":"Caughey AB, Turrentine M (2018) ACOG practice bulletin no. 190 summary: gestational diabetes mellitus. Obstet Gynecol 131(2):406\u2013408. https:\/\/doi.org\/10.1097\/aog.0000000000002498","journal-title":"Obstet Gynecol"},{"issue":"19","key":"7483_CR9","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan JA, Hague WM, Gao W, Battin MR, Moore MP (2008) Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358(19):2003\u20132015. https:\/\/doi.org\/10.1056\/NEJMoa0707193","journal-title":"N Engl J Med"},{"key":"7483_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03550-0","author":"SA Paschou","year":"2023","unstructured":"Paschou SA, Shalit A, Gerontiti E, Athanasiadou KI, Kalampokas T, Psaltopoulou T et al (2023) Efficacy and safety of metformin during pregnancy: an update. Endocrine. https:\/\/doi.org\/10.1007\/s12020-023-03550-0","journal-title":"Endocrine"},{"issue":"5","key":"7483_CR11","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s11096-022-01438-z","volume":"44","author":"F Li","year":"2022","unstructured":"Li F, Liu L, Hu Y, Marx CM, Liu W (2022) Efficacy and safety of metformin compared to insulin in gestational diabetes: a systemic review and meta-analysis of Chinese randomized controlled trials. Int J Clin Pharm 44(5):1102\u20131113. https:\/\/doi.org\/10.1007\/s11096-022-01438-z","journal-title":"Int J Clin Pharm"},{"issue":"2","key":"7483_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jcpt.13503","volume":"47","author":"K He","year":"2022","unstructured":"He K, Guo Q, Ge J, Li J, Li C, Jing Z (2022) The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: a systematic review and meta-analysis of 21 randomized controlled trials. J Clin Pharm Ther 47(2):168\u2013177. https:\/\/doi.org\/10.1111\/jcpt.13503","journal-title":"J Clin Pharm Ther"},{"issue":"8","key":"7483_CR13","doi-asserted-by":"publisher","first-page":"e1002848","DOI":"10.1371\/journal.pmed.1002848","volume":"16","author":"JL Tarry-Adkins","year":"2019","unstructured":"Tarry-Adkins JL, Aiken CE, Ozanne SE (2019) Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS\u00a0Med 16(8):e1002848. https:\/\/doi.org\/10.1371\/journal.pmed.1002848","journal-title":"PLoS\u00a0Med"},{"issue":"86","key":"7483_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20860","volume":"20","author":"D Farrar","year":"2016","unstructured":"Farrar D, Simmonds M, Griffin S, Duarte A, Lawlor DA, Sculpher M et al (2016) The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation. Health Technol Assess 20(86):1\u2013348. https:\/\/doi.org\/10.3310\/hta20860","journal-title":"Health Technol Assess"},{"issue":"3","key":"7483_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00592-007-0255-5","volume":"44","author":"K Todorova","year":"2007","unstructured":"Todorova K, Palaveev O, Petkova VB, Stefanova M, Dimitrova Z (2007) A pharmacoeconomical model for choice of a treatment for pregnant women with gestational diabetes. Acta Diabetol 44(3):144\u2013148. https:\/\/doi.org\/10.1007\/s00592-007-0255-5","journal-title":"Acta Diabetol"},{"issue":"3","key":"7483_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/dc11-1643","volume":"35","author":"EF Werner","year":"2012","unstructured":"Werner EF, Pettker CM, Zuckerwise L, Reel M, Funai EF, Henderson J et al (2012) Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 35(3):529\u2013535. https:\/\/doi.org\/10.2337\/dc11-1643","journal-title":"Diabetes Care"},{"key":"7483_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s13410-022-01048-5","author":"PG Dasari","year":"2022","unstructured":"Dasari PG, Karthikeyani B (2022) Comparison of metformin and insulin therapy for the treatment of gestational diabetes mellitus\u2014a randomised controlled trial. Int J Diabetes Dev Ctries. https:\/\/doi.org\/10.1007\/s13410-022-01048-5","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"1","key":"7483_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/1010539515612908","volume":"28","author":"PY Chen","year":"2016","unstructured":"Chen PY, Finkelstein EA, Ng MJ, Yap F, Yeo GS, Rajadurai VS et al (2016) Incremental cost-effectiveness analysis of gestational diabetes mellitus screening strategies in Singapore. Asia Pac J Public Health 28(1):15\u201325. https:\/\/doi.org\/10.1177\/1010539515612908","journal-title":"Asia Pac J Public Health"},{"key":"7483_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2020.07.580","volume":"24","author":"X Yue","year":"2021","unstructured":"Yue X, Li Y, Wu J, Guo JJ (2021) Current development and practice of pharmacoeconomic evaluation guidelines for universal health coverage in China. Value Health Reg Issues 24:1\u20135. https:\/\/doi.org\/10.1016\/j.vhri.2020.07.580","journal-title":"Value Health Reg Issues"},{"issue":"3","key":"7483_CR20","first-page":"294","volume":"58","author":"ME Nita","year":"2012","unstructured":"Nita ME, Eliaschewitz FG, Ribeiro E, Asano E, Barbosa E, Takemoto M et al (2012) Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system. Rev Assoc Med Bras (1992) 58(3):294\u2013301","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"9702","key":"7483_CR21","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/s0140-6736(09)61457-4","volume":"374","author":"WC Knowler","year":"2009","unstructured":"Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT et al (2009) 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet 374(9702):1677\u20131686. https:\/\/doi.org\/10.1016\/s0140-6736(09)61457-4","journal-title":"Lancet"},{"issue":"4","key":"7483_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/s0029-7844(00)00969-8","volume":"96","author":"M Kuppermann","year":"2000","unstructured":"Kuppermann M, Nease RF, Learman LA, Gates E, Blumberg B, Washington AE (2000) Procedure-related miscarriages and down syndrome-affected births: implications for prenatal testing based on women\u2019s preferences. Obstet Gynecol 96(4):511\u2013516. https:\/\/doi.org\/10.1016\/s0029-7844(00)00969-8","journal-title":"Obstet Gynecol"},{"issue":"12","key":"7483_CR23","doi-asserted-by":"publisher","first-page":"e018893","DOI":"10.1136\/bmjopen-2017-018893","volume":"7","author":"T Xu","year":"2017","unstructured":"Xu T, Dainelli L, Yu K, Ma L, Silva Zolezzi I, Detzel P et al (2017) The short-term health and economic burden of gestational diabetes mellitus in China: a modelling study. BMJ Open 7(12):e018893. https:\/\/doi.org\/10.1136\/bmjopen-2017-018893","journal-title":"BMJ Open"},{"issue":"3","key":"7483_CR24","doi-asserted-by":"publisher","first-page":"282.e281","DOI":"10.1016\/j.ajog.2011.06.051","volume":"205","author":"MS Ohno","year":"2011","unstructured":"Ohno MS, Sparks TN, Cheng YW, Caughey AB (2011) Treating mild gestational diabetes mellitus: a cost-effectiveness analysis. Am J Obstet Gynecol 205(3):282.e281-287. https:\/\/doi.org\/10.1016\/j.ajog.2011.06.051","journal-title":"Am J Obstet Gynecol"},{"key":"7483_CR25","volume-title":"China Guidelines for pharmacoeconomic evaluations in 2020","author":"L Guoen","year":"2020","unstructured":"Guoen L (2020) China Guidelines for pharmacoeconomic evaluations in 2020. China Market Press"},{"issue":"5","key":"7483_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/sj.jp.7210759","volume":"22","author":"L Goetzl","year":"2002","unstructured":"Goetzl L, Wilkins I (2002) Glyburide compared to insulin for the treatment of gestational diabetes mellitus: a cost analysis. J Perinatol 22(5):403\u2013406. https:\/\/doi.org\/10.1038\/sj.jp.7210759","journal-title":"J Perinatol"},{"issue":"5","key":"7483_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ajog.2021.04.229","volume":"225","author":"MJ Pic\u00f3n-C\u00e9sar","year":"2021","unstructured":"Pic\u00f3n-C\u00e9sar MJ, Molina-Vega M, Su\u00e1rez-Arana M, Gonz\u00e1lez-Mesa E, Sola-Moyano AP, Roldan-L\u00f3pez R et al (2021) Metformin for gestational diabetes study: metformin vs insulin in gestational diabetes: glycemic control and obstetrical and perinatal outcomes: randomized prospective trial. Am J Obstet Gynecol 225(5):511\u2013517","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"7483_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/00019053-199711010-00009","volume":"11","author":"KE Agro","year":"1997","unstructured":"Agro KE, Bradley CA, Mittmann N, Iskedjian M, Ilersich AL, Einarson TR (1997) Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature. Pharmacoeconomics 11(1):75\u201388. https:\/\/doi.org\/10.2165\/00019053-199711010-00009","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"7483_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/0272989x16670605","volume":"37","author":"Q Chen","year":"2017","unstructured":"Chen Q, Ayer T, Chhatwal J (2017) Sensitivity analysis in sequential decision models. Med Decis Making 37(2):243\u2013252. https:\/\/doi.org\/10.1177\/0272989x16670605","journal-title":"Med Decis Making"},{"issue":"12","key":"7483_CR30","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1016\/j.jaip.2021.10.006","volume":"9","author":"M Greenhawt","year":"2021","unstructured":"Greenhawt M, Oppenheimer J, Codispoti CD (2021) A practical guide to understanding cost-effectiveness analyses. J Allergy Clin Immunol Pract 9(12):4200\u20134207. https:\/\/doi.org\/10.1016\/j.jaip.2021.10.006","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"7483_CR31","doi-asserted-by":"publisher","first-page":"542.e541","DOI":"10.1016\/j.ajog.2011.09.004","volume":"205","author":"AG Cahill","year":"2011","unstructured":"Cahill AG, Odibo AO, Stout MJ, Grobman WA, Macones GA, Caughey AB (2011) Magnesium sulfate therapy for the prevention of cerebral palsy in preterm infants: a decision-analytic and economic analysis. Am J Obstet Gynecol 205(6):542.e541-547. https:\/\/doi.org\/10.1016\/j.ajog.2011.09.004","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"7483_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/0272989x9001000308","volume":"10","author":"WC Black","year":"1990","unstructured":"Black WC (1990) The CE plane: a graphic representation of cost-effectiveness. Med Decis Making 10(3):212\u2013214. https:\/\/doi.org\/10.1177\/0272989x9001000308","journal-title":"Med Decis Making"},{"issue":"2","key":"7483_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40273-019-00869-3","volume":"38","author":"C McCabe","year":"2020","unstructured":"McCabe C, Paulden M, Awotwe I, Sutton A, Hall P (2020) One-way sensitivity analysis for probabilistic cost-effectiveness analysis: conditional expected incremental net benefit. Pharmacoeconomics 38(2):135\u2013141. https:\/\/doi.org\/10.1007\/s40273-019-00869-3","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"7483_CR34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/14737167.2020.1819796","volume":"21","author":"EO Alenzi","year":"2021","unstructured":"Alenzi EO (2021) Cost-effectiveness analysis of polycystic ovary syndrome management and the risk of gestational diabetes in pregnant women: a decision-tree model. Expert Rev Pharmacoecon Outcomes Res 21(5):995\u2013999. https:\/\/doi.org\/10.1080\/14737167.2020.1819796","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"2","key":"7483_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bpobgyn.2014.06.009","volume":"29","author":"LK Weile","year":"2015","unstructured":"Weile LK, Kahn JG, Marseille E, Jensen DM, Damm P, Lohse N (2015) Global cost-effectiveness of GDM screening and management: current knowledge and future needs. Best Pract Res Clin Obstet Gynaecol 29(2):206\u2013224. https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.06.009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"7483_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10198-018-1006-y","volume":"20","author":"N Fitria","year":"2019","unstructured":"Fitria N, van Asselt ADI, Postma MJ (2019) Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review. Eur J Health Econ 20(3):407\u2013417. https:\/\/doi.org\/10.1007\/s10198-018-1006-y","journal-title":"Eur J Health Econ"},{"issue":"5 Pt 1","key":"7483_CR37","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/s0029-7844(01)01648-9","volume":"98","author":"S Kilpatrick","year":"2001","unstructured":"Kilpatrick S (2001) ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 32, November 2001 (replaces Technical Bulletin Number 181, June 1993, and Committee Opinion Number 241, September 2000). Thyroid disease in pregnancy. Obstet Gynecol 98(5 Pt 1):879\u2013888. https:\/\/doi.org\/10.1016\/s0029-7844(01)01648-9","journal-title":"Obstet Gynecol"},{"issue":"1","key":"7483_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/heapol\/czw085","volume":"32","author":"M Helble","year":"2017","unstructured":"Helble M, Aizawa T (2017) International trade and determinants of price differentials of insulin medicine. Health Policy Plan 32(1):1\u201310. https:\/\/doi.org\/10.1093\/heapol\/czw085","journal-title":"Health Policy Plan"},{"issue":"4","key":"7483_CR39","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40258-022-00715-2","volume":"20","author":"S Xie","year":"2022","unstructured":"Xie S, Wu J, Xie F (2022) Population norms for SF-6Dv2 and EQ-5D-5L in China. Appl Health Econ Health Policy 20(4):573\u2013585. https:\/\/doi.org\/10.1007\/s40258-022-00715-2","journal-title":"Appl Health Econ Health Policy"},{"issue":"11","key":"7483_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/14767050600863376","volume":"19","author":"CJ Homko","year":"2006","unstructured":"Homko CJ, Reece EA (2006) Insulins and oral hypoglycemic agents in pregnancy. J Matern Fetal Neonatal Med 19(11):679\u2013686. https:\/\/doi.org\/10.1080\/14767050600863376","journal-title":"J Matern Fetal Neonatal Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07483-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07483-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07483-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T12:08:25Z","timestamp":1718194105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07483-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["7483"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07483-5","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}